ImmuCell - מכפיל שווי פעילות להכנסות ICCC

ImmuCell Corporation (ICCC) management possesses deep expertise in veterinary immunology. Demand for their cattle biologicals remains stable, supporting cash flow, while the EV/Sales history illustrates the trend of market valuations. The current 3181.27 metric determines this valuation level. Efficiency gains are driven by the implementation of AI-powered robotic lines for sterile product filling.
ICCC (ImmuCell Corp.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

For ImmuCell Corporation (ICCC), the EV/Sales metric determines the enterprise value of the business, including net debt relative to sales volume, while excluding the impact of financing structure. Analyzing current EV/Sales trends allows for a comparison of market capitalization against the risks of narrow specialization in calf products and raw material cost volatility, signaling to the investor whether the asset is overbought or undervalued.